Bixiye
P34-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective August 2, 2021
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1881 - 1890 ee natiijooyinka 3563
Bixiye
P3R1-21 Update: eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021
Bixiye
2021 June Bulletins
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021
Bixiye
P35-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021
Bixiye
P33-21 Change to Medical Review Process for Outpatient Therapies Services
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021
Bixiye
QP45-21 Medical Drug Update for Botulinum Toxins (Myobloc, Botox, Dysport, Xeomin) - Commercial Products
Taariikhda uu dhaqangalayo Barnaamijka: May 26, 2021
Bixiye
QP46-21 Incorrect ID Cards Issued for Minnesota Health Care Programs Members
Taariikhda uu dhaqangalayo Barnaamijka: May 26, 2021
Bixiye
QP43-21 MHCP Pharmacy Benefit Exclusion for Jemperli and Zynlonta™
Taariikhda uu dhaqangalayo Barnaamijka: May 26, 2021
Bixiye
QP44-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Zeposia® (ozanimod)
Taariikhda uu dhaqangalayo Barnaamijka: May 26, 2021
Bixiye
2021 June Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2021